Loxapine (Loxitane, Adasuve): How This Antipsychotic Works, Dosing, and When Telehealth Is Enough

Last updated: August 23, 2026

Loxapine is a first-generation (typical) antipsychotic used for schizophrenia. Capsules come as generic loxapine succinate. The historic brand Loxitane is discontinued. A separate inhaled powder, Adasuve, treats acute agitation in adults with schizophrenia or bipolar I disorder, and only in enrolled facilities. Loxapine is not a controlled substance.

This guide covers what loxapine treats, how oral dosing usually starts, why Adasuve is not a home inhaler, common and serious side effects, and which parts of care a telehealth visit can handle. It is educational, not a diagnosis or a promise that any plan will pay for a specific medicine.

See if you may qualify for online mental health care →

What is loxapine?

According to MedlinePlus, loxapine treats symptoms of schizophrenia. It belongs to the antipsychotic group and reduces abnormal excitement in the brain. Another name is oxilapine. Capsules are taken two to four times a day. The brand Loxitane is no longer marketed; generics remain available.

The DailyMed loxapine capsule label (updated March 31, 2025) classifies loxapine as a dibenzoxazepine, chemically distinct from phenothiazines, thioxanthenes, and butyrophenones. Each capsule contains loxapine succinate equivalent to 5 mg, 10 mg, 25 mg, or 50 mg of loxapine base. DEA schedule: none.

NAMI describes loxapine as a first-generation antipsychotic that rebalances dopamine to improve thinking, mood, and behavior. Oral strengths match DailyMed: 5, 10, 25, and 50 mg. Adasuve is a 10 mg inhalation powder.

StatPearls groups loxapine with other first-generation agents in its neuroleptic medications review (high-potency typicals also include fluphenazine, trifluoperazine, haloperidol, pimozide, and perphenazine).

What does loxapine treat?

Oral capsules are indicated for schizophrenia. DailyMed notes efficacy studies enrolled newly hospitalized and chronically hospitalized acutely ill patients.

NAMI lists schizophrenia symptoms that treatment may help: hallucinations, delusions, disorganized thinking, low social drive, unclear speech, and low motivation. Positive symptoms such as hallucinations and delusions may start to ease in the first 1 to 2 weeks. Motivation and social interest often take at least 1 to 2 weeks. Full benefit can take 2 to 3 months. Treatment for schizophrenia is usually long term.

Adasuve (inhaled loxapine) is FDA-approved for acute agitation associated with schizophrenia or bipolar I disorder in adults. Mayo Clinic states a clinician gives it in a hospital or similar setting. It is not a take-home inhaler. It is available only under the Adasuve REMS program because of bronchospasm risk.

Providers sometimes use oral loxapine off-label for other psychiatric conditions. Off-label use needs a clear clinical reason and a discussion of alternatives.

How do you take oral loxapine?

MedlinePlus: take capsules two to four times a day, at about the same times. Start low. The prescriber often raises the dose over the first 7 to 10 days until symptoms are controlled, then may later lower it. Loxapine controls symptoms; it does not cure schizophrenia. Do not stop without talking to the prescriber.

DailyMed dosing (base equivalents, divided 2 to 4 times daily):

• Usual start: 10 mg twice daily.
• Severely disturbed patients: initial total up to 50 mg daily may be used.
• Raise fairly rapidly over the first 7 to 10 days until schizophrenia symptoms are controlled.
• Usual therapeutic and maintenance range: 60 mg to 100 mg daily.
• Some people respond below that range; others need more. Do not exceed 250 mg daily.
• Maintenance: lowest dose that holds symptoms; many people stay on 20 mg to 60 mg daily.

NAMI notes a typical range of 10 mg to 250 mg daily and that many people take it twice a day. Missed dose: take it when you remember unless the next dose is near. Do not double up.

If you forget a dose, MedlinePlus gives the same rule: skip if it is almost time for the next one.

What is Adasuve, and why is it different?

Adasuve is inhaled loxapine powder, 10 mg, used once for acute agitation in a registered facility. NAMI’s boxed warning for the powder: it can cause bronchospasm that may make breathing difficult or impossible. It should be given only where staff and equipment can manage acute bronchospasm, including intubation and mechanical ventilation. Screen first for asthma, COPD, other lung disease, and current airway medicines. Sedation can hide early breathing trouble.

Mayo Clinic: do not use inhaled loxapine in people with lung or breathing problems such as asthma or COPD. Pediatric safety is not established. Do not use it for dementia-related behavior problems in older adults.

Telehealth cannot administer Adasuve. A video visit can still review oral maintenance, side effects, and whether an in-person or emergency setting is safer if agitation is severe.

Browse conditions and next steps →

What side effects should you watch for?

Common effects from MedlinePlus and NAMI include drowsiness, dizziness or faintness on standing, dry mouth, constipation, restlessness, blurred vision, insomnia, nausea, weight change, and trouble with balance. Inhaled loxapine often changes taste and can cause respiratory distress.

Serious effects that need urgent care:

• Neuroleptic malignant syndrome: fever, stiff muscles, confusion, sweating, fast or irregular heartbeat. NAMI estimates NMS in under 1% of patients on antipsychotics.
• Tardive dyskinesia: rhythmic face, mouth, or jaw movements; tongue that sticks out; worm-like tongue movements. There is no reliable treatment; stopping or changing the drug is the usual first step (DailyMed).
• Acute dystonia: neck cramps, throat tightness, trouble swallowing, eyes rolling.
• Seizures. DailyMed: loxapine lowers the seizure threshold.
• Falls from dizziness or sedation.
• Allergic rash or breathing trouble.

DailyMed boxed warning: older adults with dementia-related psychosis have a higher death risk on antipsychotics. In 17 placebo-controlled trials (about 10 weeks), drug-treated patients had about 1.6 to 1.7 times the death risk of placebo. About 4.5% died versus 2.6% on placebo. Most deaths were cardiovascular or infectious. Loxapine is not approved for dementia-related psychosis.

Prolactin can rise (missed periods, milk production, lower sex drive). Long-term high prolactin can affect bone. Antipsychotics have been linked to sudden cardiac death from arrhythmia; NAMI advises the smallest effective dose and sometimes an EKG.

Who should not take loxapine?

DailyMed contraindications:

• Coma or severe drug-induced depression (alcohol, barbiturates, narcotics, and similar states).
• Known hypersensitivity to dibenzoxazepines.

Use extra caution with seizures, glaucoma, trouble urinating, heart disease, breast cancer, and a history of severe reactions to other psychiatric medicines (MedlinePlus). Alcohol can worsen sedation. Do not drive until you know how you react. Stand up slowly.

Pregnancy: safe use is not established (DailyMed). Third-trimester antipsychotic exposure can cause EPS or withdrawal in newborns (NAMI). Breastfeeding: it is not known whether loxapine passes into milk; caution applies.

Overdose: CNS and cardiovascular depression, hypotension, slow breathing, seizures, EPS, and reported renal failure. Do not use epinephrine for shock (DailyMed: it may lower blood pressure further). Poison Control: 1-800-222-1222.

When is telehealth enough?

HHS notes that telehealth remains widely used for behavioral health and can improve access and continuity. A licensed telehealth clinician can review history, discuss oral antipsychotic options, check side effects, and coordinate labs or an EKG when needed.

Oral loxapine is not a controlled substance, so federal scheduling is not the barrier. Schizophrenia care still needs a careful diagnosis, ongoing monitoring for EPS and tardive dyskinesia (NAMI recommends regular AIMS exams), and a plan for crisis. Acute agitation that might need Adasuve belongs in a facility with REMS capability, not a video visit.

Klarity Health works with 2,000+ licensed providers. Many people use telehealth for depression, anxiety, and related medication follow-up. Coverage for visits and medicines varies by plan. Verify benefits before you book. If you already take an antipsychotic such as aripiprazole (Abilify) or quetiapine (Seroquel), a clinician can compare classes rather than switch you without a reason.

Need immediate support? Call or text 988 (Suicide & Crisis Lifeline). If someone cannot stay safe, call 911.

Insurance and cost

Many commercial and Medicare plans may cover generic oral loxapine. Prior authorization is common for antipsychotics. Adasuve is a facility-administered product under REMS, so billing looks different from a retail capsule. Coverage varies by plan. Confirm benefits, copays, and pharmacy network rules before you rely on a specific fill.

This article does not state that any insurer covers loxapine. A Klarity visit is a clinical evaluation. A prescription is never guaranteed.

Frequently asked questions

Is loxapine the same as Loxitane?

Loxitane was the brand name for oral loxapine. MedlinePlus marks Loxitane as discontinued. Generic capsules remain.

Is loxapine a controlled substance?

No. DailyMed lists DEA schedule as none.

Can you get Adasuve from a telehealth visit?

No. Adasuve is given once, in an enrolled healthcare facility, because of bronchospasm risk (NAMI, Mayo Clinic).

How long until oral loxapine helps?

MedlinePlus: several weeks or longer for full benefit. NAMI: some thinking and perception symptoms may ease in 1 to 2 weeks; full benefit may take 2 to 3 months.

What is a typical oral dose?

DailyMed: often 10 mg twice daily to start, then 60 to 100 mg daily for many people, not more than 250 mg daily. Maintenance is often 20 to 60 mg daily.

Bottom line

Loxapine is a typical antipsychotic for schizophrenia, available as 5, 10, 25, and 50 mg capsules. Usual adult ranges sit well below the 250 mg daily ceiling. Adasuve is a one-time inhaled dose for agitation and stays inside REMS facilities. Boxed warnings cover dementia-related psychosis (all antipsychotics) and bronchospasm (inhaled only). Telehealth can support evaluation and oral follow-up. It cannot replace emergency or inpatient care when agitation, NMS, or severe EPS appear.

See if you may qualify →

Disclaimer: This article is for education only. It is not medical advice, a diagnosis, or a guarantee of insurance coverage. Coverage varies by plan. Verify benefits before booking. Talk with a licensed clinician about your own care. If you are in crisis, call or text 988 or call 911.